Cargando…
Retinal Toxicity in Patients Treated With Hydroxychloroquine: A Cross-Sectional Study
Hydroxychloroquine (HCQ) is an antimalarial medication that can also be used to treat autoimmune diseases. However, it can produce irreversible changes to the retina that lead to visual impairment. The aim of this study was to determine the proportion of patients treated with HCQ who develop retinal...
Autores principales: | ESPANDAR, Goldis, MOGHIMI, Jamileh, GHORBANI, Raheb, POURAZIZI, Mohsen, SEIRI, Mohammad-Ali, KHOSRAVI, Shervin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Hypothesis, Discovery & Innovation Ophthalmology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347188/ https://www.ncbi.nlm.nih.gov/pubmed/28293646 |
Ejemplares similares
-
Association between mean platelet volume and severity of rheumatoid arthritis
por: Moghimi, Jamileh, et al.
Publicado: (2017) -
Efficacy of an acquainted drug in the treatment of inflammatory low back pain: sulfasalazine under investigation
por: Moghimi, Jamileh, et al.
Publicado: (2016) -
Hydroxychloroquine-induced Retinal Toxicity
por: Yusuf, Imran H., et al.
Publicado: (2023) -
Isotretinoin-associated Sweet’s syndrome: a case report
por: Moghimi, Jamileh, et al.
Publicado: (2014) -
Femtosecond Laser-assisted Allogenic Additive Stromal Keratoplasty With or Without Excimer Laser Donor Keratomileusis for Management of Keratoconus
por: Jafarinasab, Mohammad-Reza, et al.
Publicado: (2021)